Mayne Pharma nears deal for Teva assets: source
 

Mayne Pharma nears deal for Teva assets: source
(Reuters) - Australia's Mayne Pharma Group Ltd on Tuesday said it will acquire U.S. generic products from Teva Pharmaceuticals for $652 million, helping it propel into the top 2 in the general oral...http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/news...aQ:V_sGLiPBpWU http://feeds.feedburner.com/~ff/news...aQ:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/news/...~4/pHCdqLCz-3g